Associate Professor of Neurology & Pediatrics UCSF San Francisco, California, United States
This session will review recent updates in migraine preventive treatment for children and adolescents as well as observational data on the treatment of NDPH in these age groups.
Learning Objectives:
1. To identify FDA labeled treatment(s) for migraine prevention in 6-17 year-olds.
2. To describe the results of observational work on treatment of NDPH in children and adolescents
3. To define the next steps needed in advancing researching effective treatments of headache disorders in children and adolescents.
